Prot# EMD 121974-009: Mltcntr, Opn-Lbl, Rndmzd, Uncontrolled, Phase IIa Trial in Sbjts w/Recurrent Glioblastoma Multiforme to Investigate Clinical Activity, Safety & Tolerability of EMD 121974 Administered as a Single Agent in Doses of 500mg & 2000mg

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/13/059/1/09

Funding

  • INC Research, LLC (EMD 121974-009)
  • EMD Pharmaceuticals, Inc. (EMD 121974-009)